The risk or severity of adverse effects can be increased when zaleplon is combined with maprotiline.


The risk or severity of adverse effects can be increased when Tolcapone is combined with labetalol.


The risk or severity of adverse effects can be increased when acemetacin is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when zaleplon is combined with mesoridazine.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when PSEUDOEPHEDRINE is combined with selegiline.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with fluocinonide.


The risk or severity of adverse effects can be increased when docetaxel is combined with HYDROXYPROGESTERONE CAPROATE.


The risk or severity of adverse effects can be increased when hydromorphone is combined with butorphanol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with doxepin.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when nitrazepam is combined with etizolam.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with amobarbital.


The risk or severity of adverse effects can be increased when triazolam is combined with thiamylal.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with nefazodone.


The risk or severity of adverse effects can be increased when triazolam is combined with desipramine.


The risk or severity of adverse effects can be increased when zaleplon is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when zaleplon is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with clonazepam.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with promethazine.


The risk or severity of adverse effects can be increased when zaleplon is combined with benzocaine.


The risk or severity of adverse effects can be increased when proparacaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when ramipril is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when triamterene is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with doxazosin.


The risk or severity of adverse effects can be increased when triamterene is combined with doxazosin.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with flunarizine.


The risk or severity of adverse effects can be increased when fosinopril is combined with fenbufen.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with thiopental.


The risk or severity of adverse effects can be increased when triamterene is combined with labetalol.


The risk or severity of adverse effects can be increased when pancuronium is combined with Tramadol.


The risk or severity of adverse effects can be increased when oxazepam is combined with desipramine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Imatinib.


The risk or severity of adverse effects can be increased when trandolapril is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when trandolapril is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Nepafenac is combined with haloperidol.


The risk or severity of adverse effects can be increased when propofol is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Nepafenac is combined with tolmetin.


The risk or severity of adverse effects can be increased when propofol is combined with spironolactone.


The risk or severity of adverse effects can be increased when propofol is combined with triprolidine.


The risk or severity of adverse effects can be increased when cilazapril is combined with Propacetamol.


The risk or severity of adverse effects can be increased when haloperidol is combined with butamben.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with nitrazepam.


The risk or severity of adverse effects can be increased when meperidine is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with zonisamide.


The risk or severity of adverse effects can be increased when trandolapril is combined with carvedilol.


The risk or severity of adverse effects can be increased when lidocaine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with lisinopril.


The risk or severity of adverse effects can be increased when ethanol is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when HEROIN is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when HEROIN is combined with clomipramine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with tiagabine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with ethotoin.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with prilocaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with isoflurane.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when maprotiline is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Paliperidone.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when moclobemide is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with tetracaine.


The risk or severity of adverse effects can be increased when amisulpride is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when moclobemide is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when phentolamine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when codeine is combined with brotizolam.


The risk or severity of adverse effects can be increased when codeine is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when Nabilone is combined with Sacubitril.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Cariprazine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when phentolamine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when triazolam is combined with lidocaine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with fenbufen.


The risk or severity of adverse effects can be increased when Etomidate is combined with dyclonine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with mepivacaine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Difenoxin is combined with Pizotifen.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when tropicamide is combined with Tapentadol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Articaine.


The risk or severity of adverse effects can be increased when sulpiride is combined with flunarizine.


The risk or severity of adverse effects can be increased when desoximetasone is combined with mefloquine.


The risk or severity of adverse effects can be increased when prednisone is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when chloroquine is combined with Clobetasone.


The risk or severity of adverse effects can be increased when prednisone is combined with memantine.


The risk or severity of adverse effects can be increased when timolol is combined with methazolamide.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when floctafenine is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with trimipramine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Icatibant is combined with fluocinonide.


The risk or severity of adverse effects can be increased when reserpine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when sumatriptan is combined with periciazine.


The risk or severity of adverse effects can be increased when Metipranolol is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Tramadol is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when nalbuphine is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when pargyline is combined with reserpine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when amitriptyline is combined with formoterol.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Aprepitant is combined with atorvastatin.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with thalidomide.


The risk or severity of adverse effects can be increased when fluoxetine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when dibucaine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Nepafenac is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when butabarbital is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when amisulpride is combined with desipramine.


The risk or severity of adverse effects can be increased when amifostine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with oxymorphone.


The risk or severity of adverse effects can be increased when nystatin is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when amiodarone is combined with oxycodone.


The risk or severity of adverse effects can be increased when Metixene is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when amiodarone is combined with fosinopril.


The risk or severity of adverse effects can be increased when Normethadone is combined with maprotiline.


The risk or severity of adverse effects can be increased when quetiapine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when tetracaine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when pimozide is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Rotigotine is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Rotigotine is combined with methazolamide.


The risk or severity of adverse effects can be increased when trazodone is combined with periciazine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when irbesartan is combined with hydralazine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Tramadol is combined with reserpine.


The risk or severity of adverse effects can be increased when benazepril is combined with labetalol.


The risk or severity of adverse effects can be increased when risperidone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Flupentixol is combined with tiapride.


The risk or severity of adverse effects can be increased when Dabigatran etexilate is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when Articaine is combined with butamben.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Aliskiren.


The risk or severity of adverse effects can be increased when meprobamate is combined with risperidone.


The risk or severity of adverse effects can be increased when sotalol is combined with losartan.


The risk or severity of adverse effects can be increased when Phenelzine is combined with terazosin.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with paroxetine.


The risk or severity of adverse effects can be increased when leflunomide is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when Caspofungin is combined with felodipine.


The risk or severity of adverse effects can be increased when amobarbital is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with enflurane.


The risk or severity of adverse effects can be increased when midazolam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when midazolam is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when benazepril is combined with doxazosin.


The risk or severity of adverse effects can be increased when Pentyl nitrite is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Perospirone.


The risk or severity of adverse effects can be increased when cabergoline is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when rizatriptan is combined with mesoridazine.


The risk or severity of adverse effects can be increased when nilvadipine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when zopiclone is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when acemetacin is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when rescinnamine is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when zopiclone is combined with fludiazepam.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with timolol.


The risk or severity of adverse effects can be increased when ranitidine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with dantrolene.


The risk or severity of adverse effects can be increased when sotalol is combined with enalapril.


The risk or severity of adverse effects can be increased when paroxetine is combined with loxapine.


The risk or severity of adverse effects can be increased when ethosuximide is combined with Ramelteon.


The risk or severity of adverse effects can be increased when amisulpride is combined with clemastine.


The risk or severity of adverse effects can be increased when benazepril is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when trazodone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Lacidipine is combined with spironolactone.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with edrophonium.


The risk or severity of adverse effects can be increased when prilocaine is combined with HEROIN.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Sitagliptin is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when meperidine is combined with nitrazepam.


The risk or severity of adverse effects can be increased when Olopatadine is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with butorphanol.


The risk or severity of adverse effects can be increased when benzocaine is combined with HEROIN.


The risk or severity of adverse effects can be increased when nilvadipine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when dibucaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when dibucaine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when oxybutynin is combined with butorphanol.


The risk or severity of adverse effects can be increased when docetaxel is combined with Ixabepilone.


The risk or severity of adverse effects can be increased when clorazepate is combined with thioridazine.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when bifonazole is combined with eperisone.


The risk or severity of adverse effects can be increased when estrone is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when clozapine is combined with pentazocine.


The risk or severity of adverse effects can be increased when baclofen is combined with clidinium.


The risk or severity of adverse effects can be increased when valsartan is combined with nisoldipine.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when bupivacaine is combined with dyclonine.


The risk or severity of adverse effects can be increased when loxapine is combined with tiagabine.


The risk or severity of adverse effects can be increased when clonidine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when enflurane is combined with efavirenz.


The risk or severity of adverse effects can be increased when ketorolac is combined with salicylic acid.


The risk or severity of adverse effects can be increased when Tramadol is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Icatibant is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when clonidine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when ganciclovir is combined with Entecavir.


The risk or severity of adverse effects can be increased when bupivacaine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when nortriptyline is combined with dantrolene.


The risk or severity of adverse effects can be increased when pimozide is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when benazepril is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when pentazocine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when epinephrine is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when quetiapine is combined with flunarizine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with irbesartan.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with felodipine.


The risk or severity of adverse effects can be increased when tolterodine is combined with Propiverine.


The risk or severity of adverse effects can be increased when clozapine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Dasatinib is combined with atorvastatin.


The risk or severity of adverse effects can be increased when clozapine is combined with terazosin.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with irbesartan.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with felodipine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when tretinoin is combined with betaxolol.


The risk or severity of adverse effects can be increased when Droxicam is combined with alclometasone.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with triamterene.


The risk or severity of adverse effects can be increased when zaleplon is combined with amoxapine.


The risk or severity of adverse effects can be increased when enflurane is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when zaleplon is combined with nortriptyline.


The risk or severity of adverse effects can be increased when morphine is combined with levorphanol.


The risk or severity of adverse effects can be increased when codeine is combined with ketamine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with leflunomide.


The risk or severity of adverse effects can be increased when Olopatadine is combined with clidinium.


The risk or severity of adverse effects can be increased when Torasemide is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with fenoprofen.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when pentazocine is combined with meclizine.


The risk or severity of adverse effects can be increased when pentazocine is combined with risperidone.


The risk or severity of adverse effects can be increased when phenobarbital is combined with dyclonine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with proparacaine.


The risk or severity of adverse effects can be increased when nabumetone is combined with chloroquine.


The risk or severity of adverse effects can be increased when dibucaine is combined with Normethadone.


The risk or severity of adverse effects can be increased when carisoprodol is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when demeclocycline is combined with Acitretin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with imipramine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with meclizine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when bumetanide is combined with allopurinol.


The risk or severity of adverse effects can be increased when Treprostinil is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when tiagabine is combined with dantrolene.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when Telmisartan is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when etodolac is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when budesonide is combined with mefloquine.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when tolnaftate is combined with cinnarizine.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Flupentixol.


The risk or severity of adverse effects can be increased when lithium ion is combined with Articaine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Eprosartan is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with captopril.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with Pregabalin.


The risk or severity of adverse effects can be increased when gabapentin is combined with halothane.


The risk or severity of adverse effects can be increased when nitrazepam is combined with clozapine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when temazepam is combined with thioridazine.


The risk or severity of adverse effects can be increased when diflunisal is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Salsalate.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with triprolidine.


The risk or severity of adverse effects can be increased when alprazolam is combined with paroxetine.


The risk or severity of adverse effects can be increased when Rotigotine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Rotigotine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Rotigotine is combined with quinapril.


The risk or severity of adverse effects can be increased when Rotigotine is combined with bumetanide.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with phenytoin.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when zopiclone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with clozapine.


The risk or severity of adverse effects can be increased when trandolapril is combined with etodolac.


The risk or severity of adverse effects can be increased when morniflumate is combined with leflunomide.


The risk or severity of adverse effects can be increased when Eplerenone is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when pimozide is combined with loratadine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with alclometasone.


The risk or severity of adverse effects can be increased when dyclonine is combined with Halazepam.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with loratadine.


The risk or severity of adverse effects can be increased when Tramadol is combined with ketamine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with TROLEANDOMYCIN.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with propoxyphene.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with dyclonine.


The risk or severity of adverse effects can be increased when tioconazole is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when alprazolam is combined with ondansetron.


The risk or severity of adverse effects can be increased when oxprenolol is combined with primidone.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with losartan.


The risk or severity of adverse effects can be increased when epirizole is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when methadone is combined with spironolactone.


The risk or severity of adverse effects can be increased when gabapentin is combined with triflupromazine.


The risk or severity of adverse effects can be increased when methadone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when methyldopa is combined with lithium ion.


The risk or severity of adverse effects can be increased when pergolide is combined with ROLITETRACYCLINE.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with mepivacaine.


The risk or severity of adverse effects can be increased when captopril is combined with Propacetamol.


The risk or severity of adverse effects can be increased when morphine is combined with butamben.


The risk or severity of adverse effects can be increased when butalbital is combined with fexofenadine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when lithium ion is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when pimozide is combined with Ramelteon.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when pimozide is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when thioridazine is combined with Normethadone.


The risk or severity of adverse effects can be increased when Etomidate is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Limaprost is combined with ILOPROST.


The risk or severity of adverse effects can be increased when edrophonium is combined with pilocarpine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with topiramate.


The risk or severity of adverse effects can be increased when Propiverine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when fenbufen is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when cerulenin is combined with cinnarizine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with atorvastatin.


The risk or severity of adverse effects can be increased when alprazolam is combined with zonisamide.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with mequitazine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when zopiclone is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with Clevidipine.


The risk or severity of adverse effects can be increased when zopiclone is combined with baclofen.


The risk or severity of adverse effects can be increased when terconazole is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when sulpiride is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when captopril is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when trimipramine is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when oxycodone is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when clorazepate is combined with tiapride.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with temozolomide.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with dacarbazine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with 5-Aminolevulinic acid.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Butethal.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with brotizolam.


The risk or severity of adverse effects can be increased when thiopental is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when benzoic acid is combined with isradipine.


The risk or severity of adverse effects can be increased when reserpine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when bifonazole is combined with isradipine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Olopatadine is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when diflunisal is combined with medrysone.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with meclizine.


The risk or severity of adverse effects can be increased when cabergoline is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when baclofen is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with Mirabegron.


The risk or severity of adverse effects can be increased when butenafine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when nitrofurantoin is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when tolmetin is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when pentazocine is combined with polythiazide.


The risk or severity of adverse effects can be increased when Apremilast is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with flunarizine.


The risk or severity of adverse effects can be increased when butorphanol is combined with prilocaine.


The risk or severity of adverse effects can be increased when nadolol is combined with nicotine.


The risk or severity of adverse effects can be increased when nadolol is combined with Cevimeline.


The risk or severity of adverse effects can be increased when butorphanol is combined with ethotoin.


The risk or severity of adverse effects can be increased when isoflurane is combined with mepivacaine.


The risk or severity of adverse effects can be increased when codeine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when codeine is combined with HEROIN.


The risk or severity of adverse effects can be increased when pirenzepine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when buspirone is combined with pimozide.


The risk or severity of adverse effects can be increased when tirofiban is combined with diflunisal.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with alclometasone.


The risk or severity of adverse effects can be increased when pentamidine is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when pentamidine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Eprosartan is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when nitrendipine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when aspirin is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when triamcinolone is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with spironolactone.


The risk or severity of adverse effects can be increased when Apremilast is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when benzphetamine is combined with ritodrine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with lithium ion.


The risk or severity of adverse effects can be increased when Apremilast is combined with prednisone.


The risk or severity of adverse effects can be increased when furazolidone is combined with isoetharine.


The risk or severity of adverse effects can be increased when flunarizine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when buprenorphine is combined with spironolactone.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when spironolactone is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Torasemide is combined with Amrubicin.


The risk or severity of adverse effects can be increased when pentazocine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when enflurane is combined with levodopa.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with perphenazine.


The risk or severity of adverse effects can be increased when chloroquine is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when enflurane is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when antipyrine is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when tetracaine is combined with topiramate.


The risk or severity of adverse effects can be increased when diazepam is combined with enflurane.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Metipranolol.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Mometasone.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when thiopental is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with acemetacin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with nimodipine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with butamben.


The risk or severity of adverse effects can be increased when biperiden is combined with codeine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when fenoprofen is combined with diflorasone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when selegiline is combined with mianserin.


The risk or severity of adverse effects can be increased when buspirone is combined with levorphanol.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with methazolamide.


The risk or severity of adverse effects can be increased when methocarbamol is combined with dantrolene.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Olmesartan.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with memantine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when alprazolam is combined with duloxetine.


The risk or severity of adverse effects can be increased when alprazolam is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when alprazolam is combined with chlordiazepoxide.


The risk or severity of adverse effects can be increased when alprazolam is combined with fluoxetine.


The risk or severity of adverse effects can be increased when oxazepam is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when loratadine is combined with clonidine.


The risk or severity of adverse effects can be increased when oxazepam is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when meperidine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Pirlindole is combined with Vilanterol.


The risk or severity of adverse effects can be increased when felodipine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when ethotoin is combined with clonazepam.


The risk or severity of adverse effects can be increased when ethotoin is combined with promethazine.


The risk or severity of adverse effects can be increased when meperidine is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when nitric oxide is combined with diltiazem.


The risk or severity of adverse effects can be increased when clorazepate is combined with Milnacipran.


The risk or severity of adverse effects can be increased when furazolidone is combined with brimonidine.


The risk or severity of adverse effects can be increased when sulpiride is combined with Olopatadine.


The risk or severity of adverse effects can be increased when haloprogin is combined with manidipine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Toloxatone.


The risk or severity of adverse effects can be increased when Normethadone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when haloprogin is combined with Lacidipine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with promethazine.


The risk or severity of adverse effects can be increased when haloprogin is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when haloprogin is combined with Benidipine.


The risk or severity of adverse effects can be increased when haloprogin is combined with cilnidipine.


The risk or severity of adverse effects can be increased when lorazepam is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when quazepam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when temazepam is combined with clidinium.


The risk or severity of adverse effects can be increased when ganciclovir is combined with Emtricitabine.


The risk or severity of adverse effects can be increased when oxiconazole is combined with diltiazem.


The risk or severity of adverse effects can be increased when Lacidipine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when miconazole is combined with nimesulide.


The risk or severity of adverse effects can be increased when amobarbital is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when diflunisal is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Spirapril is combined with fenoprofen.


The risk or severity of adverse effects can be increased when propofol is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when ropinirole is combined with D-mannitol.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when doxepin is combined with terbutaline.


The risk or severity of adverse effects can be increased when nortriptyline is combined with celiprolol.


The risk or severity of adverse effects can be increased when amifostine is combined with sotalol.


The risk or severity of adverse effects can be increased when amifostine is combined with Nabilone.


The risk or severity of adverse effects can be increased when Treprostinil is combined with ibuprofen.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Butethal.


The risk or severity of adverse effects can be increased when pargyline is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with hydralazine.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with Cangrelor.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when Tolcapone is combined with moclobemide.


The risk or severity of adverse effects can be increased when scopolamine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when methylergonovine is combined with mifepristone.


The risk or severity of adverse effects can be increased when ondansetron is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when ritodrine is combined with terbutaline.


The risk or severity of adverse effects can be increased when rasagiline is combined with dipivefrin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when trazodone is combined with Milnacipran.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with ambenonium.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with desipramine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with butamben.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with chloramphenicol.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with cilazapril.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Normethadone.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when LISURIDE is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when trandolapril is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when LISURIDE is combined with acetaminophen.


The risk or severity of adverse effects can be increased when Clofarabine is combined with rasagiline.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with paramethasone.


The risk or severity of adverse effects can be increased when secobarbital is combined with trazodone.


The risk or severity of adverse effects can be increased when HEROIN is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when formestane is combined with fleroxacin.


The risk or severity of adverse effects can be increased when oxymetazoline is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when nitric oxide is combined with nicardipine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when atenolol is combined with methazolamide.


The risk or severity of adverse effects can be increased when cilnidipine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when nortriptyline is combined with clenbuterol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Milnacipran.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with sevoflurane.


The risk or severity of adverse effects can be increased when Pramocaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when thalidomide is combined with cilazapril.


The risk or severity of adverse effects can be increased when papaverine is combined with cilazapril.


The risk or severity of adverse effects can be increased when methysergide is combined with Tadalafil.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when nimesulide is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when nimodipine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when methysergide is combined with diazepam.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when nimesulide is combined with fluvastatin.


The risk or severity of adverse effects can be increased when teniposide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when meprobamate is combined with clonidine.


The risk or severity of adverse effects can be increased when fexofenadine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when ATROPINE is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when quetiapine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when clozapine is combined with nadolol.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Toloxatone.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Pirlindole.


The risk or severity of adverse effects can be increased when Perospirone is combined with efavirenz.


The risk or severity of adverse effects can be increased when quazepam is combined with Remoxipride.


The risk or severity of adverse effects can be increased when thiopental is combined with butamben.


The risk or severity of adverse effects can be increased when quazepam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when meprobamate is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Mometasone is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when trimeprazine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when nimodipine is combined with irbesartan.


The risk or severity of adverse effects can be increased when clonidine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when thiothixene is combined with carisoprodol.


The risk or severity of adverse effects can be increased when thiothixene is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Olsalazine is combined with paramethasone.


The risk or severity of adverse effects can be increased when Posaconazole is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when nimodipine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when nimodipine is combined with felodipine.


The risk or severity of adverse effects can be increased when rasagiline is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when nystatin is combined with barnidipine.


The risk or severity of adverse effects can be increased when thiamylal is combined with tiapride.


The risk or severity of adverse effects can be increased when hydromorphone is combined with clidinium.


The risk or severity of adverse effects can be increased when pramipexole is combined with minoxidil.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with trimipramine.


The risk or severity of adverse effects can be increased when cabergoline is combined with venlafaxine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when butorphanol is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when oxycodone is combined with Eplerenone.


The risk or severity of adverse effects can be increased when acetazolamide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when oxycodone is combined with methazolamide.


The risk or severity of adverse effects can be increased when acemetacin is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when tropicamide is combined with oxyphenonium.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Butethal is combined with tizanidine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with tolmetin.


The risk or severity of adverse effects can be increased when meprobamate is combined with diazepam.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when Paliperidone is combined with clonidine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when lorazepam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Flupentixol is combined with methylphenidate.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when cilnidipine is combined with benazepril.


The risk or severity of adverse effects can be increased when dyclonine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when thalidomide is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with HEROIN.


The risk or severity of adverse effects can be increased when lorazepam is combined with sulpiride.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Metixene.


The risk or severity of adverse effects can be increased when codeine is combined with perphenazine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when meprobamate is combined with thiothixene.


The risk or severity of adverse effects can be increased when proparacaine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when carmustine is combined with clozapine.


The risk or severity of adverse effects can be increased when Propacetamol is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when pargyline is combined with isoproterenol.


The risk or severity of adverse effects can be increased when proparacaine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when dipyridamole is combined with diflunisal.


The risk or severity of adverse effects can be increased when amifostine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when topiramate is combined with nefazodone.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when bleomycin is combined with leflunomide.


The risk or severity of adverse effects can be increased when aspirin is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when temazepam is combined with protriptyline.


The risk or severity of adverse effects can be increased when cabergoline is combined with diazepam.


The risk or severity of adverse effects can be increased when PERHEXILINE is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with Rotigotine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Desloratadine.


The risk or severity of adverse effects can be increased when dipyridamole is combined with captopril.


The risk or severity of adverse effects can be increased when proparacaine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when cabergoline is combined with Tadalafil.


The risk or severity of adverse effects can be increased when Isoconazole is combined with flunarizine.


The risk or severity of adverse effects can be increased when secobarbital is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Clobetasone is combined with decamethonium.


The risk or severity of adverse effects can be increased when Etidocaine is combined with clonidine.


The risk or severity of adverse effects can be increased when Asenapine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Asenapine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with quetiapine.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Normethadone.


The risk or severity of adverse effects can be increased when carprofen is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when isoflurane is combined with Milnacipran.


The risk or severity of adverse effects can be increased when risperidone is combined with efavirenz.


The risk or severity of adverse effects can be increased when prazosin is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Naftifine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when carvedilol is combined with floctafenine.


The risk or severity of adverse effects can be increased when Naftifine is combined with Salsalate.


The risk or severity of adverse effects can be increased when fludiazepam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when bezafibrate is combined with sulpiride.


The risk or severity of adverse effects can be increased when Desloratadine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when PERHEXILINE is combined with fluvastatin.


The risk or severity of adverse effects can be increased when tolmetin is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when Olsalazine is combined with prednisone.


The risk or severity of adverse effects can be increased when butorphanol is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when fosinopril is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when sulindac is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when ketoconazole is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when prilocaine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Naftifine is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when spironolactone is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Bortezomib is combined with nadolol.


The risk or severity of adverse effects can be increased when butamben is combined with Normethadone.


The risk or severity of adverse effects can be increased when Naftifine is combined with felodipine.


The risk or severity of adverse effects can be increased when trapidil is combined with Apixaban.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with thiamylal.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with desipramine.


The risk or severity of adverse effects can be increased when oxybutynin is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with HEROIN.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with halothane.


The risk or severity of adverse effects can be increased when mepivacaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when butorphanol is combined with polythiazide.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with mefloquine.


The risk or severity of adverse effects can be increased when naratriptan is combined with moclobemide.


The risk or severity of adverse effects can be increased when bepridil is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when naratriptan is combined with Escitalopram.


The risk or severity of adverse effects can be increased when prazepam is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with Mirabegron.


The risk or severity of adverse effects can be increased when PROCAINAMIDE is combined with sulpiride.


The risk or severity of adverse effects can be increased when Normethadone is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when butorphanol is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when tolnaftate is combined with barnidipine.


The risk or severity of adverse effects can be increased when methylphenidate is combined with nortriptyline.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with epirizole.


The risk or severity of adverse effects can be increased when tizanidine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when nilvadipine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when Lurasidone is combined with etizolam.


The risk or severity of adverse effects can be increased when cyclophosphamide is combined with clozapine.


The risk or severity of adverse effects can be increased when hydralazine is combined with Nebivolol.


The risk or severity of adverse effects can be increased when flunisolide is combined with metoclopramide.


The risk or severity of adverse effects can be increased when Icatibant is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when codeine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when zotepine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when glutethimide is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when glutethimide is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when glutethimide is combined with flunarizine.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with Echothiophate.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with etizolam.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when lisinopril is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when PERHEXILINE is combined with pravastatin.


The risk or severity of adverse effects can be increased when aspirin is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with norfloxacin.


The risk or severity of adverse effects can be increased when Butethal is combined with zonisamide.


The risk or severity of adverse effects can be increased when Agomelatine is combined with clidinium.


The risk or severity of adverse effects can be increased when Halazepam is combined with efavirenz.


The risk or severity of adverse effects can be increased when Butethal is combined with tiagabine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with diflorasone.


The risk or severity of adverse effects can be increased when dicyclomine is combined with methadone.


The risk or severity of adverse effects can be increased when secobarbital is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Perospirone.


The risk or severity of adverse effects can be increased when buspirone is combined with tiapride.


The risk or severity of adverse effects can be increased when ropinirole is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when sevoflurane is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Micafungin is combined with nicardipine.


The risk or severity of adverse effects can be increased when perphenazine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Udenafil is combined with alprostadil.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Pregabalin is combined with paroxetine.


The risk or severity of adverse effects can be increased when caffeine is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when rasagiline is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when clemastine is combined with Retigabine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when chlorpropamide is combined with Carbocisteine.


The risk or severity of adverse effects can be increased when enalapril is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with nicotine.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with Cevimeline.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with baclofen.


The risk or severity of adverse effects can be increased when flurazepam is combined with clidinium.


The risk or severity of adverse effects can be increased when losartan is combined with Metipranolol.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when losartan is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when zaleplon is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when sulpiride is combined with butalbital.


The risk or severity of adverse effects can be increased when Lacidipine is combined with nifedipine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with butamben.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when spironolactone is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Lacidipine is combined with papaverine.


The risk or severity of adverse effects can be increased when amobarbital is combined with Retigabine.


The risk or severity of adverse effects can be increased when sulpiride is combined with butamben.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with terazosin.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Etidocaine.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when spironolactone is combined with nicardipine.


The risk or severity of adverse effects can be increased when sulindac is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when Nepafenac is combined with difluprednate.


The risk or severity of adverse effects can be increased when Nepafenac is combined with halcinonide.


The risk or severity of adverse effects can be increased when alclometasone is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when trandolapril is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with maprotiline.


The risk or severity of adverse effects can be increased when tiapride is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Posaconazole is combined with cinnarizine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with dantrolene.


The risk or severity of adverse effects can be increased when secobarbital is combined with ethotoin.


The risk or severity of adverse effects can be increased when flunarizine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Idelalisib is combined with leflunomide.


The risk or severity of adverse effects can be increased when butabarbital is combined with duloxetine.


The risk or severity of adverse effects can be increased when halothane is combined with Perospirone.


The risk or severity of adverse effects can be increased when butabarbital is combined with chlordiazepoxide.


The risk or severity of adverse effects can be increased when Escitalopram is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when ibuprofen is combined with antipyrine.


The risk or severity of adverse effects can be increased when benzocaine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when bromazepam is combined with Agomelatine.


The risk or severity of adverse effects can be increased when naratriptan is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when amiodarone is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when azelastine is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when spironolactone is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when sulindac is combined with difluprednate.


The risk or severity of adverse effects can be increased when cocaine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when salicylamide is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when amoxapine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when salicylamide is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with ethotoin.


The risk or severity of adverse effects can be increased when isoflurane is combined with triamterene.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Regorafenib.


The risk or severity of adverse effects can be increased when hydromorphone is combined with midazolam.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Spirapril is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Talniflumate is combined with oxaprozin.


The risk or severity of adverse effects can be increased when lidocaine is combined with clidinium.


The risk or severity of adverse effects can be increased when minocycline is combined with Alitretinoin.


The risk or severity of adverse effects can be increased when enflurane is combined with sertraline.


The risk or severity of adverse effects can be increased when codeine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when codeine is combined with alprazolam.


The risk or severity of adverse effects can be increased when codeine is combined with Eszopiclone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Lofexidine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when codeine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when codeine is combined with loxapine.


The risk or severity of adverse effects can be increased when STIRIPENTOL is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Riociguat.


The risk or severity of adverse effects can be increased when Tavaborole is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when terconazole is combined with pravastatin.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with clemastine.


The risk or severity of adverse effects can be increased when etodolac is combined with budesonide.


The risk or severity of adverse effects can be increased when ketamine is combined with duloxetine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when ketamine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when tolterodine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when nilvadipine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when nilvadipine is combined with bumetanide.


The risk or severity of adverse effects can be increased when midazolam is combined with butalbital.


The risk or severity of adverse effects can be increased when Sacubitril is combined with chloroquine.


The risk or severity of adverse effects can be increased when miconazole is combined with Pinaverium.


The risk or severity of adverse effects can be increased when chloroquine is combined with equilin.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with tizanidine.


The risk or severity of adverse effects can be increased when glutethimide is combined with promethazine.


The risk or severity of adverse effects can be increased when glutethimide is combined with clonazepam.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Perospirone.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Tramadol.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with clonidine.


The risk or severity of adverse effects can be increased when ipratropium is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with METAXALONE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with metolazone.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with buspirone.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with salicylamide.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Demecarium is combined with methacholine.


The risk or severity of adverse effects can be increased when Sitagliptin is combined with quinapril.


The risk or severity of adverse effects can be increased when halothane is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with ondansetron.


The risk or severity of adverse effects can be increased when gabapentin is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with tiagabine.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with Demecarium.


The risk or severity of adverse effects can be increased when isoflurane is combined with selegiline.


The risk or severity of adverse effects can be increased when Vecuronium is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when clozapine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when pentobarbital is combined with benzocaine.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Mometasone.


The risk or severity of adverse effects can be increased when pentobarbital is combined with vigabatrin.


The risk or severity of adverse effects can be increased when pentobarbital is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with maprotiline.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with mesoridazine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with metoclopramide.


The risk or severity of adverse effects can be increased when benzphetamine is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with metolazone.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with doxepin.


The risk or severity of adverse effects can be increased when desipramine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Vilanterol.


The risk or severity of adverse effects can be increased when desipramine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when triflupromazine is combined with benzocaine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with nefazodone.


The risk or severity of adverse effects can be increased when pimozide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when alclofenac is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when maprotiline is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when tenoxicam is combined with medrysone.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with desipramine.


The risk or severity of adverse effects can be increased when Apremilast is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with glutethimide.


The risk or severity of adverse effects can be increased when moclobemide is combined with clenbuterol.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Caspofungin is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Melatonin is combined with tiapride.


The risk or severity of adverse effects can be increased when morphine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when moclobemide is combined with Bambuterol.


The risk or severity of adverse effects can be increased when flurazepam is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Isoflurophate is combined with pilocarpine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with triamterene.


The risk or severity of adverse effects can be increased when nitric oxide is combined with oxprenolol.


The risk or severity of adverse effects can be increased when thioridazine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with zopiclone.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with efavirenz.


The risk or severity of adverse effects can be increased when meperidine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when meperidine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with diltiazem.


The risk or severity of adverse effects can be increased when meperidine is combined with Etomidate.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with felbamate.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with triprolidine.


The risk or severity of adverse effects can be increased when diazepam is combined with clomipramine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with methocarbamol.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with amobarbital.


The risk or severity of adverse effects can be increased when etodolac is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when alprazolam is combined with sertraline.


The risk or severity of adverse effects can be increased when griseofulvin is combined with flunarizine.


The risk or severity of adverse effects can be increased when dyclonine is combined with halothane.


The risk or severity of adverse effects can be increased when alprazolam is combined with pimozide.


The risk or severity of adverse effects can be increased when celecoxib is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with fosinopril.


The risk or severity of adverse effects can be increased when Tapentadol is combined with D-mannitol.


The risk or severity of adverse effects can be increased when dyclonine is combined with clomipramine.


The risk or severity of adverse effects can be increased when clomipramine is combined with dobutamine.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when loratadine is combined with clidinium.


The risk or severity of adverse effects can be increased when alprazolam is combined with topiramate.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when Eprosartan is combined with floctafenine.


The risk or severity of adverse effects can be increased when barnidipine is combined with minoxidil.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with clomipramine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with oxprenolol.


The risk or severity of adverse effects can be increased when nilvadipine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when isoflurane is combined with propofol.


The risk or severity of adverse effects can be increased when nitric oxide is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when propofol is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Propacetamol.


The risk or severity of adverse effects can be increased when clorazepate is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when pentobarbital is combined with ethotoin.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with diflunisal.


The risk or severity of adverse effects can be increased when Efonidipine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when pentobarbital is combined with isoflurane.


The risk or severity of adverse effects can be increased when ketorolac is combined with leflunomide.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with primidone.


The risk or severity of adverse effects can be increased when Amrinone is combined with lovastatin.


The risk or severity of adverse effects can be increased when cisplatin is combined with topotecan.


The risk or severity of adverse effects can be increased when oxazepam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with tetracaine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with clidinium.


The risk or severity of adverse effects can be increased when diclofenac is combined with betamethasone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Iloperidone.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when Rotigotine is combined with trandolapril.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with polythiazide.


The risk or severity of adverse effects can be increased when sumatriptan is combined with trimipramine.


The risk or severity of adverse effects can be increased when zopiclone is combined with clomipramine.


The risk or severity of adverse effects can be increased when quinapril is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when sulindac is combined with Mometasone.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Drospirenone.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with difluprednate.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with brotizolam.


The risk or severity of adverse effects can be increased when CALCIUM GLUCONATE is combined with ceftriaxone.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Agomelatine is combined with nefazodone.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Normethadone.


The risk or severity of adverse effects can be increased when nitric oxide is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Agomelatine is combined with doxepin.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when tropicamide is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when methysergide is combined with Ivacaftor.


The risk or severity of adverse effects can be increased when mecamylamine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when thioridazine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when methysergide is combined with Lomitapide.


The risk or severity of adverse effects can be increased when procyclidine is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when thioridazine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when triazolam is combined with tiapride.


The risk or severity of adverse effects can be increased when secobarbital is combined with gabapentin.


The risk or severity of adverse effects can be increased when Rufinamide is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Rufinamide is combined with chloral hydrate.